Fundamental Mechanisms of Autoantibody-Induced Impairments on Ion Channels and Synapses in Immune-Mediated Cerebellar Ataxias.
Animals
Antigen-Antibody Reactions
Autoantibodies
/ immunology
Autoantigens
/ immunology
Autoimmune Diseases of the Nervous System
/ immunology
Cerebellar Ataxia
/ immunology
Cerebellum
/ metabolism
Humans
Ion Channels
/ antagonists & inhibitors
Nerve Tissue Proteins
/ immunology
Neural Cell Adhesion Molecules
/ metabolism
Neuronal Plasticity
Neurotransmitter Agents
/ metabolism
Protein Transport
Purkinje Cells
/ metabolism
Synapses
/ immunology
anti-GAD 65 antibody
anti-metabotropic glutamate receptor 1 antibody
anti-voltage-gated Ca channel antibody
autoantibodies
cerebellar ataxias
immune-mediated cerebellar ataxias
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
13 Jul 2020
13 Jul 2020
Historique:
received:
31
05
2020
revised:
07
07
2020
accepted:
09
07
2020
entrez:
17
7
2020
pubmed:
17
7
2020
medline:
3
3
2021
Statut:
epublish
Résumé
In the last years, different kinds of limbic encephalitis associated with autoantibodies against ion channels and synaptic receptors have been described. Many studies have demonstrated that such autoantibodies induce channel or receptor dysfunction. The same mechanism is discussed in immune-mediated cerebellar ataxias (IMCAs), but the pathogenesis has been less investigated. The aim of the present review is to evaluate what kind of cerebellar ion channels, their related proteins, and the synaptic machinery proteins that are preferably impaired by autoantibodies so as to develop cerebellar ataxias (CAs). The cerebellum predictively coordinates motor and cognitive functions through a continuous update of an internal model. These controls are relayed by cerebellum-specific functions such as precise neuronal discharges with potassium channels, synaptic plasticity through calcium signaling pathways coupled with voltage-gated calcium channels (VGCC) and metabotropic glutamate receptors 1 (mGluR1), a synaptic organization with glutamate receptor delta (GluRδ), and output signal formation through chained GABAergic neurons. Consistently, the association of CAs with anti-potassium channel-related proteins, anti-VGCC, anti-mGluR1, and GluRδ, and anti-glutamate decarboxylase 65 antibodies is observed in IMCAs. Despite ample distributions of AMPA and GABA receptors, however, CAs are rare in conditions with autoantibodies against these receptors. Notably, when the autoantibodies impair synaptic transmission, the autoimmune targets are commonly classified into three categories: release machinery proteins, synaptic adhesion molecules, and receptors. This physiopathological categorization impacts on both our understanding of the pathophysiology and clinical prognosis.
Identifiants
pubmed: 32668612
pii: ijms21144936
doi: 10.3390/ijms21144936
pmc: PMC7404345
pii:
doi:
Substances chimiques
Autoantibodies
0
Autoantigens
0
Ion Channels
0
Nerve Tissue Proteins
0
Neural Cell Adhesion Molecules
0
Neurotransmitter Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
J Neurosci. 2012 Oct 31;32(44):15345-58
pubmed: 23115173
Orphanet J Rare Dis. 2013 Jun 05;8:82
pubmed: 23738610
Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8328-33
pubmed: 9653186
J Neurosci. 1999 Nov 1;19(21):9149-59
pubmed: 10531418
J Neurosci. 2008 Feb 6;28(6):1291-300
pubmed: 18256249
Front Cell Neurosci. 2018 Sep 19;12:311
pubmed: 30283304
J Physiol. 2019 Feb;597(3):903-920
pubmed: 30382582
Handb Clin Neurol. 2018;155:313-332
pubmed: 29891069
Brain. 2014 Aug;137(Pt 8):2178-92
pubmed: 24951641
Brain. 2003 Jun;126(Pt 6):1409-18
pubmed: 12764061
Handb Clin Neurol. 2016;133:219-45
pubmed: 27112680
Eur J Neurosci. 2001 May;13(10):1902-12
pubmed: 11403683
J Neurosci. 2009 Mar 11;29(10):3242-51
pubmed: 19279261
J Neuroinflammation. 2015 Sep 17;12:166
pubmed: 26377085
Ann Neurol. 1999 Aug;46(2):263-7
pubmed: 10443895
Handb Clin Neurol. 2012;103:189-99
pubmed: 21827889
J Autoimmun. 2019 Sep;103:102284
pubmed: 31176559
J Neurol. 2010 Jan;257(1):59-62
pubmed: 19629562
Neuron. 2000 Nov;28(2):499-510
pubmed: 11144359
J Chem Neuroanat. 1997 Oct;13(4):219-41
pubmed: 9412905
JAMA Neurol. 2014 Aug;71(8):1009-16
pubmed: 24934144
J Neurol. 2019 Jan;266(1):195-206
pubmed: 30460450
Cerebellum. 2012 Sep;11(3):651-65
pubmed: 20734177
Autoimmun Rev. 2016 Oct;15(10):970-4
pubmed: 27485013
J Neurosci. 2000 Jun 1;20(11):4145-55
pubmed: 10818150
Cerebellum Ataxias. 2015 Nov 10;2:14
pubmed: 26561527
Brain. 2015 Jan;138(Pt 1):94-109
pubmed: 25392198
Neuropathology. 2010 Apr;30(2):182-8
pubmed: 20102521
Neurosci Res. 1997 Oct;29(2):151-60
pubmed: 9359464
N Engl J Med. 2000 Jan 6;342(1):21-7
pubmed: 10620645
Acta Neurol Scand. 2011 Mar;123(3):175-80
pubmed: 20456245
J Neurosci. 2015 Aug 12;35(32):11433-44
pubmed: 26269648
Curr Opin Neurol. 2016 Aug;29(4):496-506
pubmed: 27262149
Ann Neurol. 2007 Jun;61(6):544-51
pubmed: 17600364
N Engl J Med. 2001 Dec 27;345(26):1870-6
pubmed: 11756577
Brain. 2016 Apr;139(Pt 4):1079-93
pubmed: 26945884
Neurology. 2014 Nov 11;83(20):1797-803
pubmed: 25320100
Cerebellum. 2012 Jun;11(2):457-87
pubmed: 22161499
Brain. 2018 Nov 1;141(11):3144-3159
pubmed: 30346486
Arch Neurol. 2001 Feb;58(2):225-30
pubmed: 11176960
J Immunol Res. 2017;2017:2913297
pubmed: 28386570
Ann Neurol. 2018 Jan;83(1):40-51
pubmed: 29244234
Curr Opin Neurol. 2019 Jun;32(3):484-492
pubmed: 30694927
Prog Brain Res. 2014;210:1-30
pubmed: 24916287
Ann Neurol. 2003 Jan;53(1):21-8
pubmed: 12509844
Neuron. 2013 Oct 30;80(3):675-90
pubmed: 24183019
Curr Opin Cell Biol. 2010 Aug;22(4):496-505
pubmed: 20561775
Neuron. 2003 Oct 9;40(2):361-79
pubmed: 14556714
No To Hattatsu. 2004 Jan;36(1):60-3
pubmed: 14737866
Expert Rev Clin Immunol. 2013 Nov;9(11):1043-53
pubmed: 24168411
J Physiol. 1980 Aug;305:197-213
pubmed: 7441553
Ann Neurol. 2013 Jan;73(1):120-8
pubmed: 23225603
Neuron. 1995 Apr;14(4):755-62
pubmed: 7718238
J Neurosci. 2005 Feb 9;25(6):1481-92
pubmed: 15703402
Physiol Rev. 2017 Apr;97(2):839-887
pubmed: 28298428
J Neurol. 2020 Jul;267(7):2083-2089
pubmed: 32221776
Neurology. 2002 Sep 10;59(5):764-6
pubmed: 12221175
Front Syst Neurosci. 2020 Apr 09;14:19
pubmed: 32327978
J Neuroinflammation. 2015 Sep 17;12:168
pubmed: 26377319
Cerebellum Ataxias. 2017 Sep 21;4:16
pubmed: 28944066
Neurology. 2017 Mar 14;88(11):1012-1020
pubmed: 28202703
Brain. 2006 Feb;129(Pt 2):290-2
pubmed: 16434422
Neuron. 2017 Jan 18;93(2):409-424
pubmed: 28103481
J Physiol. 1995 Jun 1;485 ( Pt 2):419-35
pubmed: 7545231
Fluids Barriers CNS. 2014 Jul 27;11:16
pubmed: 25089184
Neuron. 2015 Aug 19;87(4):781-96
pubmed: 26291161
J Neurol Sci. 2003 Apr 15;208(1-2):51-6
pubmed: 12639725
Neurology. 2016 Aug 2;87(5):521-8
pubmed: 27371488
Front Behav Neurosci. 2015 Mar 27;9:78
pubmed: 25870548
J Physiol. 1982 Mar;324:113-34
pubmed: 7097592
Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17846-51
pubmed: 16303868
J Neurol Sci. 2008 Aug 15;271(1-2):186-90
pubmed: 18534624
Nat Neurosci. 2000 Dec;3(12):1266-73
pubmed: 11100147
J Neurosci. 2012 Sep 12;32(37):12909-14
pubmed: 22973014
Neurology. 1992 Oct;42(10):1944-50
pubmed: 1407577
Curr Neuropharmacol. 2019;17(1):33-58
pubmed: 30221603
Ann Neurol. 2003 Mar;53(3):325-36
pubmed: 12601700
Cell. 1994 Oct 21;79(2):377-88
pubmed: 7954803
J Neurosci. 2017 Nov 22;37(47):11335-11352
pubmed: 29054881
Lancet Neurol. 2010 Jan;9(1):67-76
pubmed: 19962348
Cerebellum. 2012 Sep;11(3):605-8
pubmed: 22806980
Brain Dev. 2007 May;29(4):254-6
pubmed: 17049194
Neurology. 2014 Apr 29;82(17):1521-8
pubmed: 24696508
J Med Case Rep. 2014 Apr 08;8:119
pubmed: 24712889
Neuron. 2008 Aug 14;59(3):392-8
pubmed: 18701065
Annu Rev Physiol. 2002;64:355-405
pubmed: 11826273
PLoS One. 2010 Aug 12;5(8):e12119
pubmed: 20711348
J Physiol. 1987 Dec;394:463-80
pubmed: 2832595
Neurol Neuroimmunol Neuroinflamm. 2017 Jun 14;4(4):e371
pubmed: 28638854
Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):E371-9
pubmed: 25583485
J Cereb Blood Flow Metab. 2017 Dec;37(12):3683-3694
pubmed: 28273726
Eur J Neurol. 2018 Oct;25(10):1290-1298
pubmed: 29904974
Ann Neurol. 1994 Jan;35(1):74-80
pubmed: 8285596
Cerebellum. 2019 Apr;18(2):153-156
pubmed: 30343467
Neuron. 2000 Mar;25(3):635-47
pubmed: 10774731
Arch Neurol. 2010 May;67(5):627-30
pubmed: 20457964
PLoS One. 2015 Mar 16;10(3):e0121364
pubmed: 25774787
J Neuroimmunol. 2014 Jun 15;271(1-2):53-5
pubmed: 24793897
J Neurosci. 2002 Jun 1;22(11):4388-98
pubmed: 12040045
Brain Res. 1987 Sep 8;420(1):11-21
pubmed: 3676746
Nat Rev Neurosci. 2002 Nov;3(11):896-902
pubmed: 12415297
Front Cell Neurosci. 2015 Feb 24;9:47
pubmed: 25759640
J Comp Neurol. 1988 Aug 8;274(2):168-77
pubmed: 3209740
Orphanet J Rare Dis. 2011 Feb 04;6:3
pubmed: 21294897
Lancet Neurol. 2014 Mar;13(3):276-86
pubmed: 24462240
Neurology. 2011 Jul 12;77(2):179-89
pubmed: 21747075
Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2705-10
pubmed: 18272482
J Neurophysiol. 2004 Nov;92(5):2831-43
pubmed: 15212420
J Neurosci. 2010 Apr 28;30(17):5866-75
pubmed: 20427647
Nature. 1992 Apr 16;356(6370):601-4
pubmed: 1313949
Science. 1991 Dec 13;254(5038):1656-9
pubmed: 1721243
J Neurol Neurosurg Psychiatry. 2017 Apr;88(4):301-309
pubmed: 27965395
Brain. 2010 Sep;133(9):2734-48
pubmed: 20663977
Experientia. 1964 Sep 15;20(9):515-6
pubmed: 5856344
Brain Struct Funct. 2018 Apr;223(3):1565-1587
pubmed: 29177691
J Neural Transm (Vienna). 2014 Aug;121(8):957-68
pubmed: 24402576
Neurology. 2008 Oct 14;71(16):1291-2
pubmed: 18852446
J Neurosci. 2013 Mar 20;33(12):5162-74
pubmed: 23516282
J Neurosci. 2011 Apr 6;31(14):5235-43
pubmed: 21471358
Neuron. 2018 Sep 5;99(5):985-998.e6
pubmed: 30122381
J Neuroimmunol. 2013 Mar 15;256(1-2):94-6
pubmed: 23332614
Science. 2010 Apr 16;328(5976):363-8
pubmed: 20395510
J Neurosci. 2008 May 28;28(22):5752-5
pubmed: 18509036
Neurology. 2015 Jun 16;84(24):2403-12
pubmed: 25979696
Ann Clin Transl Neurol. 2014 Mar 1;1(3):180-189
pubmed: 24707504
Proc Natl Acad Sci U S A. 1986 Mar;83(6):1945-9
pubmed: 2419913
Physiol Rev. 2001 Jul;81(3):1143-95
pubmed: 11427694
Neuron. 2011 Apr 14;70(1):43-50
pubmed: 21482355
Neuro Oncol. 2014 Jun;16(6):771-8
pubmed: 24637228
Neuron. 2018 Oct 10;100(1):91-105.e9
pubmed: 30146304
Nat Rev Neurol. 2012 Jun 19;8(7):380-90
pubmed: 22710628
J Neuroimmunol. 2013 Aug 15;261(1-2):53-9
pubmed: 23726906
J Neurosci. 2006 May 3;26(18):4820-5
pubmed: 16672655
J Neurol Neurosurg Psychiatry. 2020 Jul 10;:
pubmed: 32651251
Neuron. 2014 May 7;82(3):635-44
pubmed: 24811382
Neuron. 2001 Aug 16;31(3):463-75
pubmed: 11516402
Lancet Neurol. 2008 Dec;7(12):1091-8
pubmed: 18851928
J Neurol Sci. 2000 Apr 1;175(1):40-4
pubmed: 10785255
Channels (Austin). 2015;9(5):245-52
pubmed: 26218135
Neurosci Res. 2014 Jun;83:64-8
pubmed: 24607546
eNeuro. 2018 Feb 12;5(1):
pubmed: 29464191
Annu Rev Physiol. 2018 Feb 10;80:243-262
pubmed: 29166241
J Neuroimmunol. 2013 Oct 15;263(1-2):155-8
pubmed: 23958353
Brain Dev. 2009 Jan;31(1):83-5
pubmed: 18554833
Brain Dev. 2007 May;29(4):224-6
pubmed: 17008044
No To Hattatsu. 2011 Jan;43(1):41-5
pubmed: 21400931
Neurology. 2010 Mar 9;74(10):857-9
pubmed: 20211911
Cerebellum. 2016 Apr;15(2):213-32
pubmed: 25823827
Exp Brain Res. 1966;1(1):1-16
pubmed: 5910941
J Neuroinflammation. 2015 Sep 17;12:167
pubmed: 26377184
Ann Neurol. 2009 Apr;65(4):424-34
pubmed: 19338055
J Neurol Neurosurg Psychiatry. 2007 Feb;78(2):190-2
pubmed: 17119008
J Neurosci. 2014 Jul 23;34(30):9891-904
pubmed: 25057192
Nat Neurosci. 2003 Aug;6(8):869-76
pubmed: 12833050
Brain. 1997 Aug;120 ( Pt 8):1279-300
pubmed: 9278623
J Neurol. 2010 Apr;257(4):509-17
pubmed: 20035430